Trial Outcomes & Findings for Functional Connectivity as a Biomarker of rTMS (NCT NCT03050801)
NCT ID: NCT03050801
Last Updated: 2021-04-12
Results Overview
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which applies magnetic pulses to the brain via a coil inducing an electrical current in the brain. Stimulation is typically applied at sufficient intensity to trigger action potentials in nearby neurons.The motor threshold is defined as the minimum percentage of the stimulator output to elicit a motor evoked potential. Repetitive TMS (rTMS) was delivered at 100% of the motor evoked potential threshold with repeated magnetic pulses at a frequency of 20 Hz. Functional MRI (fMRI) measures the change in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different parts of the brain. FC is the similarity in fluctuations of these fMRI signals and suggest how strongly two regions communicate with each other. We measured how TMS can change FC between specific areas of the brain. A positive score suggests a stronger communication between regions of the brain.
COMPLETED
PHASE1/PHASE2
68 participants
Changes are calculated before and the day after rTMS
2021-04-12
Participant Flow
Healthy Volunteers with an age range of 18-50 years were recruited for participation in Experiment 1 and 2. HV participants self-referred either directly or via the NIH Clinical Research Volunteer Program. Interested participants were pre-screened over the telephone. Participants with Traumatic Brain Injury were not recruited for this study, as Experiment 3 was not performed.
Participants were pre-screened by telephone and scheduled for consent and formal screening. Participants meeting eligibility were enrolled in the experiment. Study participants were either enrolled in Experiment 1 or 2. Experiment 1 was designed to determine the optimal number of rTMS sessions to produce a meaningful change in brain connectivity. Experiment 2 used the optimal number of rTMS sessions identified in Experiment 1, to stimulate different brain regions to study the effect on memory.
Participant milestones
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex Stimulation
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Experiment 1
STARTED
|
3
|
13
|
8
|
0
|
0
|
0
|
|
Experiment 1
COMPLETED
|
3
|
6
|
6
|
0
|
0
|
0
|
|
Experiment 1
NOT COMPLETED
|
0
|
7
|
2
|
0
|
0
|
0
|
|
Experiment 2
STARTED
|
0
|
0
|
0
|
21
|
19
|
4
|
|
Experiment 2
COMPLETED
|
0
|
0
|
0
|
15
|
15
|
2
|
|
Experiment 2
NOT COMPLETED
|
0
|
0
|
0
|
6
|
4
|
2
|
Reasons for withdrawal
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex Stimulation
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Experiment 1
Lost to Follow-up
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Experiment 1
Physician Decision
|
0
|
3
|
0
|
0
|
0
|
0
|
|
Experiment 1
Change of experimental design
|
0
|
3
|
0
|
0
|
0
|
0
|
|
Experiment 1
Unable to obtain critical rTMS measure
|
0
|
0
|
2
|
0
|
0
|
0
|
|
Experiment 2
Lost to Follow-up
|
0
|
0
|
0
|
1
|
1
|
0
|
|
Experiment 2
Physician Decision
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Experiment 2
Pregnancy
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Experiment 2
Withdrawal by Subject
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Experiment 2
Poor data quality
|
0
|
0
|
0
|
4
|
1
|
0
|
|
Experiment 2
Discomfort during stimulation
|
0
|
0
|
0
|
0
|
0
|
2
|
Baseline Characteristics
Functional Connectivity as a Biomarker of rTMS
Baseline characteristics by cohort
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
n=3 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
n=6 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
n=6 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal rTMS Stimulation - 3 Days
n=2 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex over 3 days
|
Total
n=47 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
3 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
15 Participants
n=4 Participants
|
15 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
47 Participants
n=8 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Age, Continuous
|
28.33 Years
STANDARD_DEVIATION 9.24 • n=5 Participants
|
23.83 Years
STANDARD_DEVIATION 2.64 • n=7 Participants
|
26.67 Years
STANDARD_DEVIATION 3.14 • n=5 Participants
|
25.60 Years
STANDARD_DEVIATION 5.46 • n=4 Participants
|
24.93 Years
STANDARD_DEVIATION 4.40 • n=21 Participants
|
21.00 Years
STANDARD_DEVIATION 2.82 • n=8 Participants
|
25.27 Years
STANDARD_DEVIATION 4.88 • n=8 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
6 Participants
n=4 Participants
|
6 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
19 Participants
n=8 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
9 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
28 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
6 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
9 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
3 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
13 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
38 Participants
n=8 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
10 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
1 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
5 Participants
n=8 Participants
|
|
Race (NIH/OMB)
White
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
10 Participants
n=21 Participants
|
1 Participants
n=8 Participants
|
24 Participants
n=8 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
4 Participants
n=8 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
4 Participants
n=8 Participants
|
PRIMARY outcome
Timeframe: Changes are calculated before and the day after rTMSPopulation: Healthy volunteers participants
Transcranial Magnetic Stimulation (TMS) is a non-invasive technique which applies magnetic pulses to the brain via a coil inducing an electrical current in the brain. Stimulation is typically applied at sufficient intensity to trigger action potentials in nearby neurons.The motor threshold is defined as the minimum percentage of the stimulator output to elicit a motor evoked potential. Repetitive TMS (rTMS) was delivered at 100% of the motor evoked potential threshold with repeated magnetic pulses at a frequency of 20 Hz. Functional MRI (fMRI) measures the change in oxygenated blood in the brain; at rest these levels fluctuate over time. These fluctuations can be similar between different parts of the brain. FC is the similarity in fluctuations of these fMRI signals and suggest how strongly two regions communicate with each other. We measured how TMS can change FC between specific areas of the brain. A positive score suggests a stronger communication between regions of the brain.
Outcome measures
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
n=3 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
n=6 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
n=6 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days
n=2 Participants
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Functional Connectivity (FC) Changes Between the Left Hippocampus and Left Parietal Cortex
|
-0.03 Change in z-transformed R-value
Standard Deviation 0.089
|
0.13 Change in z-transformed R-value
Standard Deviation 0.202
|
0.02 Change in z-transformed R-value
Standard Deviation 0.123
|
-0.01 Change in z-transformed R-value
Standard Deviation 0.109
|
-0.05 Change in z-transformed R-value
Standard Deviation 0.141
|
0.03 Change in z-transformed R-value
Standard Deviation 0.088
|
PRIMARY outcome
Timeframe: Changes are calculated before and the day after rTMS and before and 7-14 days after rTMSPopulation: Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.
Participants studied 20 face-word pairs, and after a short delay, were required to recall the word associated with each pair. The number of correctly remembered pairs was recorded. rTMS was administered over different regions of the brain over 3 days. The Associative Memory test was administered at baseline (within a week before the first rTMS session), 1 day after the last rTMS session, and again 7-14 days after the last rTMS session. We calculated improvements on this task by subtracting the number of successfully remembered pairs 1 day after stimulation from the number remembered at baseline ("Changes one day after rTMS"). We also calculated whether these improvements lasted longer by subtracting the number of successfully remembered pairs 7-14 days after stimulation from the number remembered at baseline ("Changes 7-14 days after rTMS"). Positive scores represent increases in associative memory.
Outcome measures
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
n=15 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
n=2 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Associative Memory Test Score Changes
Changes one day after rTMS
|
0.08 Change in proportion of remembered pairs
Standard Deviation 0.133
|
0.01 Change in proportion of remembered pairs
Standard Deviation 0.166
|
0.03 Change in proportion of remembered pairs
Standard Deviation 0.035
|
—
|
—
|
—
|
|
Associative Memory Test Score Changes
Changes 7-14 days after rTMS
|
0.08 Change in proportion of remembered pairs
Standard Deviation 0.173
|
0.02 Change in proportion of remembered pairs
Standard Deviation 0.149
|
0.13 Change in proportion of remembered pairs
Standard Deviation 0.071
|
—
|
—
|
—
|
SECONDARY outcome
Timeframe: Changes are calculated before and the day after rTMS, and before and 7-14 days after rTMSPopulation: Experiment 1 identified the optimal number of rTMS sessions to be applied in Experiment 2. The optimal number of rTMS sessions, i.e., 3 days, was applied to different regions of the brain in Experiment 2. Therefore, only the Experiment 2 data is reported for this outcome measure.
Participants learn implicit, probabilistic relationships between stimuli and responses through feedback. 1, 2 and 3 card combinations of 4 possible cards are presented on a computer; the subject is asked to predict whether it will be rainy or fine. After each prediction, the subject receives corrective feedback. Each card is independently associated with one outcome with a fixed probability.The WPT was administered at baseline and 1 day after and 7-14 days after the last rTMS session. Scores at each time point represent the proportion of responses associated with a reward (optimal responses). We calculated improvement by subtracting the number of optimal responses 1 day after stimulation from the number at baseline (Changes one day after rTMS). We also calculated if these improvements lasted longer by subtracting the number of optimal responses 7-14 days after stimulation from the number at baseline (Changes 7-14 days after rTMS).Positive scores represent increases in implicit memory.
Outcome measures
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
n=15 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
n=15 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
n=2 Participants
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Implicit Weather Prediction Task (WPT)
Changes one day after rTMS
|
-0.03 Change in proportion of optimal response
Standard Deviation 0.158
|
0.06 Change in proportion of optimal response
Standard Deviation 0.196
|
0.06 Change in proportion of optimal response
Standard Deviation 0.02
|
—
|
—
|
—
|
|
Implicit Weather Prediction Task (WPT)
Changes 7-14 days after rTMS
|
-0.02 Change in proportion of optimal response
Standard Deviation 0.143
|
0.02 Change in proportion of optimal response
Standard Deviation 0.156
|
0.01 Change in proportion of optimal response
Standard Deviation 0.03
|
—
|
—
|
—
|
Adverse Events
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
Experiment 2: Vertex rTMS Stimulation - 3 Days
Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Experiment 1: Parietal Cortex rTMS Stimulation - 1 Day
n=3 participants at risk
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 1 day
|
Experiment 1: Parietal Cortex rTMS Stimulation - 3 Days
n=13 participants at risk
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 1: Parietal Cortex rTMS Stimulation - 4 Days
n=8 participants at risk
Experiment 1
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 4 days
|
Experiment 2: Parietal Cortex rTMS Stimulation - 3 Days
n=21 participants at risk
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Parietal Cortex over 3 days
|
Experiment 2: Vertex rTMS Stimulation - 3 Days
n=19 participants at risk
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Vertex, over 3 days
|
Experiment 2: Prefrontal Cortex rTMS Stimulation - 3 Days
n=4 participants at risk
Experiment 2
rTMS: Altering the connectivity of trans-synaptic pathways with rTMS applied to the Prefrontal Cortex, over 3 days
|
|---|---|---|---|---|---|---|
|
Nervous system disorders
Migraine
|
0.00%
0/3 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/13 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/8 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
4.8%
1/21 • Number of events 1 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/19 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/4 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
|
Nervous system disorders
Intolerance to stimulation
|
0.00%
0/3 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/13 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/8 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/21 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
0.00%
0/19 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
50.0%
2/4 • Number of events 2 • Adverse events were collected during and immediately after study procedures. Participants experiencing adverse events at completion of study procedures, were followed until AE resolution.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place